Company Overview
Snapshot
Founded in January 2006 by Yitzhak Cohen, Tikun Olam operates with 11–50 employees. The company was acquired by Cannbit in November 2019, marking a significant milestone in its trajectory within the medical cannabis industry.
Business overview
Tikun Olam specializes in the Health Tech & Life Sciences sector, focusing on medical cannabis. The company breeds proprietary cannabis strains and develops standardized, accurately dosed products, emphasizing increased efficacy of active ingredients. Its products are utilized in ongoing clinical trials within Israel's regulated medical cannabis market. Additionally, Tikun Olam operates Tikun Olam Care, a professional nursing clinic providing personalized treatment to over 20,000 patients for various medical conditions.
Strategic signal
In August 2022, Tikun Olam received approval to export medical cannabis to Europe. This development is a strong signal of the company's expanding international reach and regulatory compliance, indicating significant growth potential in new markets for its medical cannabis products.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant acquisition event for Tikun Olam?
- Tikun Olam was acquired by Cannbit in November 2019. This acquisition was valued at $23 million, in addition to 5% of Cannbit's shares and other amounts based on the company's success.
- What is Tikun Olam's primary focus in the medical cannabis industry?
- Tikun Olam specializes in breeding proprietary cannabis strains and developing standardized, accurately dosed products. The company's production techniques are focused on increasing the efficacy of the plants' active ingredients.
- What is the status of Tikun Olam's products in clinical settings?
- Tikun Olam's products are used in a number of ongoing clinical trials in Israel's regulated medical cannabis market.
- What services does Tikun Olam provide to patients?
- Tikun Olam operates Tikun Olam Care, a professional cannabis nursing clinic that provides safe and personalized treatment for a variety of medical conditions to more than 20,000 patients of all ages.
- What was a key market expansion for Tikun Olam in 2022?
- In August 2022, Tikun Olam received approval to export medical cannabis to Europe, signifying an expansion into international markets.